Trump, Pfizer and White House
Pfizer shelves haemophilia gene therapy Beqvez
PFE offers a 6.73% dividend yield and growth potential, driven by strategic acquisitions, R&D, and discounted valuations.
Pfizer Inc. (NYSE:PFE – Get Free Report) was the target of some unusual options trading activity on Friday. Stock traders ...
We can refer to full-year 2019 revenue of about $51 billion and the company's comments about potential revenue of more than ...
Pfizer may appeal to income investors, but growth prospects remain uncertain. Read why PFE stock might struggle to gain ...
Pfizer is doubling down on its fight against cancer with a 60-second ad set to air during the first quarter of the game.
All this negativity, however, does open up an opportunity for investors to buy the stock at a discount. Despite being a top ...
An archived Facebook post claimed that Pfizer has released a list of side effects for COVID vaccine. The claim by the user is ...
Pfizer's strong Q4 2024 results showcase growth in cancer drugs and Vyndaqel sales. Learn why PFE stock is a top pick for ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback